
CAR T-Cell Targeting of Prominin-1 to Inhibit Glioblastoma Multiforme Proliferation
A computational study comparing nanobody binding to Prominin-1 to explore potential targeting strategies for glioblastoma immunotherapy. Findings remain predictive and require laboratory validation.






